Drugmakers set to raise U.S. prices on at least 500 drugs in January--analysis
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
...
The group believes doctors received bonuses and incentives for giving medications, like remdesivir, to sick family members. They claim their loved ones got worse after receiving the medication....
Submitted by mike kraft on
A new report published in Open Forum Infectious Diseases demonstrates that, despite the proven effectiveness of Paxlovid and molnupiravir against severe COVID-19 outcomes, uptake of these two antivirals remains low among Americans with COVID.
...
Submitted by mike kraft on
Two systematic reviews by US federal agencies on the possible link between antiviral treatment for COVID-19 and viral rebound—one specifically on Paxlovid—find no consistent association. The studies were published yesteray in Morbidity and Mortality Weekly Report.
...
Submitted by mike kraft on
Submitted by mike kraft on
...
Federal pandemic aid also helped slow the rate of rural hospital closures. But as facilities contend with lingering inflation, workforce shortages and declining populations, the pace of those closures is picking up again.
Telehealth offers a chance to bridge the gap in hospital deserts.
...
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
...
Three widely held misconceptions reflect and contribute to polarization. For each, there’s a kernel of truth that appears to support the misconception, but the reality is clear.
...
Submitted by mike kraft on
...